Download PDF
Aktuelle Rheumatologie 2008; 33(6): 337-341
DOI: 10.1055/s-2008-1027446
Originalarbeit

© Georg Thieme Verlag KG Stuttgart · New York

Prognoseabschätzung bei früher (rheumatoider) Arthritis – Optimierung durch moderne Bildgebung?

Prognosis in Early (Rheumatoid) Arthritis – The Value of MRI and ArthrosonographyB. Ostendorf1 , F. McQueen2 , A. Scherer3 , M. Schneider1
  • 1Klinik für Endokrinologie, Diabetologie und Rheumatologie, Heinrich-Heine Universität Düsseldorf
  • 2Department of Molecular Medicine and Pathology, University of Auckland, Faculty of Medicine and Health Sciences
  • 3Institut für Diagnostische Radiologie, Heinrich-Heine-Universität Düsseldorf
Further Information

Publication History

Publication Date:
15 December 2008 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Therapie der rheumatoiden Arthritis beginnt für die Patienten mit einer schlechten Prognose heute schon am besten vor der Diagnose, andere Patienten mit der gleichen Diagnose benötigen möglicherweise niemals eine krankheitsmodifizierende Therapie. Klassische Indikatoren für den frühzeitigen Einsatz einer sog. Basistherapie sind die Zahl der geschwollenen Gelenke, die Dauer der Gelenkschwellung, der Nachweis von Rheumafaktoren und/oder CCP-Antikörpern und das Vorhandsein von Erosionen. Die zusammenfassende Bewertung dieser Parameter, z. B. im Visser-Score, erlaubt auch für den Rheumatologen eine gewisse Objektivierung seiner Entscheidung für oder gegen eine Basistherapie bei frühen Verlaufsformen einer Arthritis. In Ergänzung zu den genannten klinischen Parametern ist der initiale Nachweis eines Knochenödems mittels MRT der beste Prädiktor für radiologische Progression. Auch für diese Verlaufbeurteilung sind Ultraschall und MRT wesentlicher sensitiver als sog. Aktivitätsscores. Die Persistenz einer Synovitis und sicher der Nachweis von Knochenödemen bei adäquater Therapie mit klassischen DMARDs könnten Indikation zu einer Therapie mit Biologika sein, deren Effektivität dann auch mittels MRT überprüft werden sollte.

Abstract

In RA patients with a poor prognosis, a disease-modifying antirheumatic therapy should best be started even before diagnosis, in other cases with RA there is no need for such an intervention. Clinical predictors of a poor prognosis are the number of swollen joints, the duration of arthritis, a positive rheumatoid factor and/or positivity for CCP antibodies and erosions in X-ray. The weighted rating of these parameters, e. g., using the Visser score, is of some help to objectify the pro or contra for a therapy with disease-modifying antirheumatic drugs (DMARD). MRI detection of bone oedema provides the best predictor for erosions. In evaluation responses to therapy, MRI as well as arthrosonography are more sensitive than any clinical parameter and should therefore be used to verify remission before tapering DMARDs and to evaluate the efficacy of biologicals.

Schlüsselwörter

Früharthritis - Prognosekriterien - MRT - Knochenödem

Key words

early arthritis - prognostic criteria - MRI - bone oedema

Literatur

  • 1 Anderson J J, Wells G, Verhoeven A C. et al . Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.  Arthritis Rheum. 2000;  43 22-29
    Google Scholar
  • 2 Arnett F C, Edworthy S M, Bloch D A. et al . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.  Arthritis Rheum. 1988;  31 315-324
    Google Scholar
  • 3 Benton N, Stewart N, Crabbe J. et al . MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years.  Ann Rheum Dis. 2004;  63 555-561
    Google Scholar
  • 4 Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis.  Arthritis Rheum. 2003;  48 1771-1774
    Google Scholar
  • 5 Borg G, Allander E, Lund B. Auranofin improves outcome in early rheumatoid arthritis.  Journal of Rheumatology. 1988;  15 1747-1754
    Google Scholar
  • 6 Brennan P, Harrison B, Barrett E. et al . A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study.  BMJ. 1996;  313 471-476
    Google Scholar
  • 7 Brown A K, Quinn M A, Karim Z. et al . Emery Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.  Arthritis Rheum. 2006;  54 3761-3773
    Google Scholar
  • 8 Brown A K, Roberts T E, Wakefield R J. et al . The challenges of integrating ultrasonography into routine rheumatology practice: addressing the needs of clinical rheumatologists.  Rheumatology. 2007;  46 821-829
    Google Scholar
  • 9 Bukhari M, Lunt M, Harrison B J. et al . Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort.  Arthritis Rheum. 2002;  46 906-912
    Google Scholar
  • 10 Bukhari M A, Wiles N J, Lunt M. et al . Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study.  Arthritis Rheum. 2003;  48 46-53
    Google Scholar
  • 11 Combe B, Dougados M, Goupille P. et al . Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study.  Arthritis Rheum. 2001;  44 1736-1743
    Google Scholar
  • 12 Cruyssen B V, Hoffman I EA, Peene I. et al . Prediction models for rheumatoid arthritis during diagnostic workup: evaluation of combinations rheumatoid factor, anti-citrullinated protein/peptide antibodies and the HLA shared epitope.  Ann Rheum Dis. 2007;  66 1072-1077
    Google Scholar
  • 13 Egsmose C, Lund B, Borg G. et al . Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.  J Rheumatol. 1995;  22 2208-2213
    Google Scholar
  • 14 Emery P. Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?.  Br J Rheumatol. 1995;  34 (Suppl 2) 87-90
    Google Scholar
  • 15 Farragher T M, Lunt M, Bunn D K. et al . Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk arthritis register.  Ann Rheum Dis. 2007;  66 486-492
    Google Scholar
  • 16 Forslind K, Ahlmen M, Eberhardt K. et al . Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).  Ann Rheum Dis. 2004;  63 1090-1095
    Google Scholar
  • 17 Forslind K, Larsson E M, Johansson A. et al . Detection of joint pathology by magnetic resonance imaging in patients with early rheumatoid arthritis.  Br J Rheumatol. 1997;  36 683-688
    Google Scholar
  • 18 Fries J F, Williams C A, Morfeld D. et al . Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies.  Arthritis Rheum. 1996;  39 616-622
    Google Scholar
  • 19 Guillemin F, Gerard N, Leeuwen van M. et al . Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients.  J Rheumatol. 2003;  30 2585-2589
    Google Scholar
  • 20 Jansen L M, Horst-Bruinsma I E, Schaardenburg van der D. et al . Predictors of radiographic joint damage in patients with early rheumatoid arthritis.  Ann Rheum Dis. 2001;  60 924-927
    Google Scholar
  • 21 Jansen van L MA, Schaardenburg van D, Horst-Bruinsma I E. et al . One year outcome of undifferntiated polyarthritis.  Ann Rheum Dis. 2002;  61 700-703
    Google Scholar
  • 22 Jones van der G, Halbert J, Crotty M. et al . The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials.  Rheumatology. 2003;  42 6-13
    Google Scholar
  • 23 Kastbom A, Strandberg G, Lindroos A. et al . Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).  Ann Rheum Dis. 2004;  63 1085-1089
    Google Scholar
  • 24 Lard L R, Boers M, Verhoeven A. et al . Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage.  Arthritis Rheum. 2002;  46 899-905
    Google Scholar
  • 25 Lindquist E, Saxne T, Geborel P. et al . Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.  Ann Rheum Dis. 2002;  61 1055-1059
    Google Scholar
  • 26 Lunt M, Symmons P M, Silman A J. An evaluation of the decision tree format of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis.  Arthritis Rheum. 2005;  52 2277-2283
    Google Scholar
  • 27 Machold K P, Eberl G, Leeb B F. et al . Early arthritis therapy: rationale and current approach.  J Rheumatol. 1998;  53 13-19
    Google Scholar
  • 28 McQueen F M, Ostendorf B. What is MRI bone oedema in rheumatoid arthritis and why does it matter.  Arthritis Res Ther. 2006;  8 222
    Google Scholar
  • 29 McQueen F M, Benton N, Crabbe J. et al . What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease.  Ann Rheum Dis. 2001;  60 859-868
    Google Scholar
  • 30 McQueen F M, Benton N, Perry D. et al . Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis.  Arthritis Rheum. 2003;  48 1814-1827
    Google Scholar
  • 31 Meyer O, Labarre C, Dougados M. et al . Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.  Ann Rheum Dis. 2003;  62 120-126
    Google Scholar
  • 32 Morel J, Combe B. How to predict prognosis in early rheumatoid arthritis.  Best Practice & Res Clin Rheumatol. 2005;  19 137-146
    Google Scholar
  • 33 Mottonen T, Hannonen P, Korpela M. et al . Delay to institution of therapy and induction of remission using single- drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.  Arthritis Rheum. 2002;  46 894-898
    Google Scholar
  • 34 Mottonen T, Paimela L, Ahonen J. et al . Outcome in patients with early rheumatoid arthritis treated according to the “sawtooth” strategy.  Arthritis Rheum. 1996;  39 996-1005
    Google Scholar
  • 35 Mottonen T, Paimela L, Leirisalo-Repo M. et al . Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with “sawtooth” strategy.  Ann Rheum Dis. 1998;  57 533-539
    Google Scholar
  • 36 Munro R, Hampson R, McEntegart A. et al . Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study.  Ann Rheum Dis. 1998;  57 88-93
    Google Scholar
  • 37 Naredo E, Collado P, Cruz A. et al . Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression.  Arthritis Rheum. 2007;  57 116-124
    Google Scholar
  • 38 O’Dell J R. Treating rheumatoid arthritis early: a window of opportunity?.  Arthritis Rheum. 2002;  46 283-285
    Google Scholar
  • 39 Ostergaard M, Hansen M, Stoltenberg M. et al . Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis.  Arthritis Rheum. 1999;  42 918-929
    Google Scholar
  • 40 Paulus H E, Di Primeo D, Sharp J T. et al . Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.  J Rheumatol. 2004;  31 470-481
    Google Scholar
  • 41 Peltomaa R, Paimela L, Kautiainen H. et al . Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.  Ann Rheum Dis. 2002;  61 889-894
    Google Scholar
  • 42 Schellekens G A, Visser H, Jong B AW. et al . The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.  Arthritis Rheum. 2000;  43 155-163
    Google Scholar
  • 43 Schneider de M, Lelgemann M, Abholz H H. et al .DGRh-Leitlinie – Management der frühen rheumatoiden Arthritis. Darmstadt; Steinkopff Verlag 2007 2. Auflage
    Google Scholar
  • 44 Sugimoto H, Takeda A, Hyodoh K. Early-stage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis.  Radiology. 2000;  216 569-575
    Google Scholar
  • 45 Symmons D P, Hazes J M, Silman A J. Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis.  J Rheumatol. 2003;  30 902-904
    Google Scholar
  • 46 Tsakonas E, Fitzgerald A A, Fitzcharles M A. et al . Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.  J Rheumatol. 2000;  27 623-629
    Google Scholar
  • 47 Aken van J, Dongen van H, le Cessie S. et al . Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study.  Ann Rheum Dis. 2006;  65 20-25
    Google Scholar
  • 48 Dongen van H, Aken van J, Lard L R. et al . Efficay of methotrexate treatment in patients with probable rheumatoid arthritis.  Arthritis Rheum. 2007;  56 1424-1432
    Google Scholar
  • 49 Zeben van D, Hazes J M, Zwinderman A H. et al . The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset.  J Rheumatol. 1994;  21 1620-1625
    Google Scholar
  • 50 Zeben van D, Hazes J M, Zwinderman A H. et al . Factors predicting outcome of rheumatoid arthritis: results of a follow up study.  J Rheumatol. 1993;  20 1288-1296
    Google Scholar
  • 51 vd Heijde A, Remme C A, Hofman D M. et al . Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis.  Arthritis Rheum. 1995;  38 1466-1474
    Google Scholar
  • 52 Vencovsky J, Machacek S, Sedova L. et al . Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.  Ann Rheum Dis. 2003;  62 427-430
    Google Scholar
  • 53 Visser H, le Cessie S, Vos K. et al . How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis.  Arthritis Rheum. 2002;  46 357-365
    Google Scholar
  • 54 Visser H. Early diagnosis of rheumatoid arthritis.  Best Practice & Res Clin Rheumatol. 2005;  19 55-72
    Google Scholar
  • 55 Wakefield R J, Gibbon W W, Conaghan P G. et al . The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography.  Arthritis Rheum. 2000;  43 2762-2770
    Google Scholar
  • 56 Wiles N J, Dunn G, Barrett E M. et al . One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline.  J Rheumatol. 2000;  27 2360-2366
    Google Scholar
  • 57 Wiles N J, Lunt M, Barrett E M. et al . Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity.  Arthritis Rheum. 2001;  44 1033-1042
    Google Scholar
  • 58 Wolfe F, Mitchell D M, Sibley J T. et al . The mortality of rheumatoid arthritis.  Arthritis Rheum. 1994;  37 481-494
    Google Scholar

Prof. Dr. Matthias Schneider

Klinik für Endokrinologie Diabetologie und Rheumatologie, Heinrich-Heine-Universität

Moorenstr. 5

40225 Düsseldorf

Phone: ++ 49/2 11/8 11 78 17

Fax: ++ 49/2 11/8 11 64 55

Email: schneider@rheumanet.org

      >